What is Quiver Bioscience?
Quiver Bioscience is a pioneering technology company dedicated to creating groundbreaking medicines for the brain. The company leverages advanced single-cell imaging and multi-omics technologies to construct the world's most comprehensive neuronal insight map, termed the "Genomic Positioning System." This innovative approach integrates scalable human models, cutting-edge proprietary engineering, and sophisticated AI/ML models to pinpoint novel therapeutic targets and identify optimal drug candidates for patients. The company's focus on uncovering new biology positions it at the forefront of neurological drug discovery.
How much funding has Quiver Bioscience raised?
Quiver Bioscience has raised a total of $2M across 1 funding round:
Grant
$2M
Grant (2025): $2M with participation from National Institutes of Health (NIH
Key Investors in Quiver Bioscience
National Institutes of Health (NIH
The National Institutes of Health (NIH), a leading biomedical research agency of the U.S. government, provides significant grant funding to advance scientific discovery and therapeutic development, particularly in areas critical to public health.
What's next for Quiver Bioscience?
With this substantial enterprise-level backing, Quiver Bioscience is poised for significant expansion and advancement in its therapeutic development pipeline. The company's strategic utilization of its "Genomic Positioning System" and AI/ML capabilities is expected to accelerate the identification of novel drug targets and the progression of promising molecules through preclinical and clinical stages. This investment will likely fuel further research into complex brain diseases and enhance the company's capacity to deliver innovative treatments to patients in need.
See full Quiver Bioscience company page
